Annual CFI
-$66.00 K
-$2.12 M-103.21%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual cash flow from investing activities is -$66.00 thousand, with the most recent change of -$2.12 million (-103.21%) on December 31, 2022.
- During the last 3 years, ELOX annual CFI has risen by +$33.46 million (+99.80%).
- ELOX annual CFI is now -100.20% below its all-time high of $33.79 million, reached on December 31, 2020.
Performance
ELOX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$233.00 K
+$219.00 K+1564.29%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly cash flow from investing activities is $233.00 thousand, with the most recent change of +$219.00 thousand (+1564.29%) on September 30, 2023.
- Over the past year, ELOX quarterly CFI has increased by +$281.00 thousand (+585.42%).
- ELOX quarterly CFI is now -98.52% below its all-time high of $15.79 million, reached on March 31, 2020.
Performance
ELOX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$258.00 K
+$281.00 K+1221.74%
September 30, 2023
Summary
- As of February 8, 2025, ELOX TTM cash flow from investing activities is $258.00 thousand, with the most recent change of +$281.00 thousand (+1221.74%) on September 30, 2023.
- Over the past year, ELOX TTM CFI has increased by +$344.00 thousand (+400.00%).
- ELOX TTM CFI is now -99.40% below its all-time high of $42.87 million, reached on September 30, 2020.
Performance
ELOX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ELOX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -103.2% | +585.4% | +400.0% |
| 3 y3 years | +99.8% | -96.5% | -99.4% |
| 5 y5 years | +42.1% | +230.2% | +100.8% |
ELOX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -103.2% | at low | at high | +585.4% | -87.5% | +341.1% |
| 5 y | 5-year | -100.2% | +99.8% | -98.5% | +437.7% | -99.4% | +100.8% |
| alltime | all time | -100.2% | +99.8% | -98.5% | +101.3% | -99.4% | +100.6% |
Eloxx Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $233.00 K(+1564.3%) | $258.00 K(-1221.7%) |
| Jun 2023 | - | $14.00 K(+27.3%) | -$23.00 K(-47.7%) |
| Mar 2023 | - | $11.00 K(>+9900.0%) | -$44.00 K(-33.3%) |
| Dec 2022 | -$66.00 K(-103.2%) | $0.00(-100.0%) | -$66.00 K(-23.3%) |
| Sep 2022 | - | -$48.00 K(+585.7%) | -$86.00 K(-19.6%) |
| Jun 2022 | - | -$7000.00(-36.4%) | -$107.00 K(-105.2%) |
| Mar 2022 | - | -$11.00 K(-45.0%) | $2.04 M(-0.5%) |
| Dec 2021 | $2.06 M(-93.9%) | -$20.00 K(-71.0%) | $2.06 M(-1.0%) |
| Sep 2021 | - | -$69.00 K(-103.2%) | $2.08 M(-76.7%) |
| Jun 2021 | - | $2.15 M(>+9900.0%) | $8.89 M(-50.6%) |
| Mar 2021 | - | $0.00(0.0%) | $18.00 M(-46.7%) |
| Dec 2020 | $33.79 M(-200.8%) | $0.00(-100.0%) | $33.79 M(-21.2%) |
| Sep 2020 | - | $6.75 M(-40.0%) | $42.87 M(+110.3%) |
| Jun 2020 | - | $11.25 M(-28.7%) | $20.38 M(-331.8%) |
| Mar 2020 | - | $15.79 M(+73.9%) | -$8.79 M(-73.8%) |
| Dec 2019 | -$33.52 M(>+9900.0%) | $9.08 M(-157.7%) | -$33.52 M(-21.6%) |
| Sep 2019 | - | -$15.74 M(-12.2%) | -$42.78 M(+58.0%) |
| Jun 2019 | - | -$17.92 M(+100.4%) | -$27.08 M(+194.3%) |
| Mar 2019 | - | -$8.94 M(+4895.5%) | -$9.20 M(+2802.8%) |
| Dec 2018 | -$317.00 K(+178.1%) | -$179.00 K(+383.8%) | -$317.00 K(+129.7%) |
| Sep 2018 | - | -$37.00 K(-15.9%) | -$138.00 K(+36.6%) |
| Jun 2018 | - | -$44.00 K(-22.8%) | -$101.00 K(+77.2%) |
| Mar 2018 | - | -$57.00 K(<-9900.0%) | -$57.00 K(+2180.0%) |
| Dec 2017 | -$114.00 K(-340.0%) | - | - |
| Sep 2017 | - | $0.00(0.0%) | -$2500.00(-105.3%) |
| Jun 2017 | - | $0.00(-100.0%) | $47.50 K(0.0%) |
| Jun 2017 | $47.50 K(>+9900.0%) | - | - |
| Mar 2017 | - | -$2500.00(<-9900.0%) | $47.50 K(-5.0%) |
| Dec 2016 | - | $0.00(-100.0%) | $50.00 K(0.0%) |
| Sep 2016 | - | $50.00 K(>+9900.0%) | $50.00 K(>+9900.0%) |
| Jun 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2016 | - | $0.00(0.0%) | $457.80 K(+68.4%) |
| Dec 2015 | - | $0.00(-100.0%) | $271.80 K(-204.7%) |
| Jun 2015 | -$259.60 K(-140.1%) | $457.80 K(-346.1%) | -$259.60 K(-176.5%) |
| Mar 2015 | - | -$186.00 K(-5.4%) | $339.20 K(-8.0%) |
| Dec 2014 | - | -$196.60 K(-41.3%) | $368.80 K(-19.0%) |
| Sep 2014 | - | -$334.80 K(-131.7%) | $455.10 K(-29.7%) |
| Jun 2014 | $646.90 K(-222.3%) | $1.06 M(-775.6%) | $647.00 K(-219.0%) |
| Mar 2014 | - | -$156.40 K(+41.8%) | -$543.70 K(+2.8%) |
| Dec 2013 | - | -$110.30 K(-22.8%) | -$528.70 K(+0.7%) |
| Sep 2013 | - | -$142.90 K(+6.6%) | -$524.90 K(-0.8%) |
| Jun 2013 | -$529.00 K(+17.4%) | -$134.10 K(-5.2%) | -$529.00 K(+5.4%) |
| Mar 2013 | - | -$141.40 K(+32.8%) | -$501.70 K(+6.4%) |
| Dec 2012 | - | -$106.50 K(-27.6%) | -$471.60 K(+0.6%) |
| Sep 2012 | - | -$147.00 K(+37.6%) | -$468.70 K(+4.0%) |
| Jun 2012 | -$450.50 K | -$106.80 K(-4.0%) | -$450.50 K(-24.1%) |
| Mar 2012 | - | -$111.30 K(+7.4%) | -$593.20 K(-9.9%) |
| Dec 2011 | - | -$103.60 K(-19.6%) | -$658.60 K(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$128.80 K(-48.4%) | -$685.60 K(-0.1%) |
| Jun 2011 | -$686.40 K(-384.8%) | -$249.50 K(+41.2%) | -$686.50 K(-238.7%) |
| Mar 2011 | - | -$176.70 K(+35.3%) | $494.90 K(-182.4%) |
| Dec 2010 | - | -$130.60 K(+0.7%) | -$600.90 K(-1262.3%) |
| Sep 2010 | - | -$129.70 K(-113.9%) | $51.70 K(-78.5%) |
| Jun 2010 | $241.00 K(-118.1%) | $931.90 K(-173.2%) | $241.00 K(-10.5%) |
| Mar 2010 | - | -$1.27 M(-343.8%) | $269.20 K(-83.2%) |
| Dec 2009 | - | $522.00 K(+775.8%) | $1.60 M(+92.1%) |
| Sep 2009 | - | $59.60 K(-93.8%) | $834.20 K(-162.5%) |
| Jun 2009 | -$1.33 M(+31.5%) | $960.10 K(+1489.6%) | -$1.33 M(-46.7%) |
| Mar 2009 | - | $60.40 K(-124.6%) | -$2.50 M(-8.1%) |
| Dec 2008 | - | -$245.90 K(-88.3%) | -$2.72 M(-13.7%) |
| Sep 2008 | - | -$2.11 M(+907.3%) | -$3.16 M(+211.4%) |
| Jun 2008 | -$1.01 M(-1094.0%) | -$209.30 K(+30.7%) | -$1.01 M(+146.8%) |
| Mar 2008 | - | -$160.10 K(-76.4%) | -$410.80 K(-183.7%) |
| Dec 2007 | - | -$679.60 K(-2036.2%) | $490.90 K(-387.2%) |
| Sep 2007 | - | $35.10 K(-91.1%) | -$170.90 K(-267.7%) |
| Jun 2007 | $102.00 K(-96.0%) | $393.80 K(-46.9%) | $101.90 K(-84.8%) |
| Mar 2007 | - | $741.60 K(-155.3%) | $670.00 K(+13.5%) |
| Dec 2006 | - | -$1.34 M(-535.7%) | $590.10 K(-69.8%) |
| Sep 2006 | - | $307.90 K(-68.0%) | $1.95 M(-23.3%) |
| Jun 2006 | $2.55 M(-427.6%) | $961.90 K(+45.4%) | $2.55 M(-487.2%) |
| Mar 2006 | - | $661.70 K(+2840.9%) | -$657.90 K(-37.7%) |
| Dec 2005 | - | $22.50 K(-97.5%) | -$1.06 M(+245.2%) |
| Sep 2005 | - | $901.20 K(-140.2%) | -$306.10 K(-60.6%) |
| Jun 2005 | -$777.60 K(-64.7%) | -$2.24 M(-953.0%) | -$777.50 K(-57.6%) |
| Mar 2005 | - | $263.00 K(-66.0%) | -$1.84 M(+12.6%) |
| Dec 2004 | - | $773.00 K(+79.9%) | -$1.63 M(-24.6%) |
| Sep 2004 | - | $429.80 K(-113.0%) | -$2.16 M(-1.8%) |
| Jun 2004 | -$2.20 M(-246.6%) | -$3.30 M(-803.9%) | -$2.20 M(-213.9%) |
| Mar 2004 | - | $469.00 K(+94.1%) | $1.93 M(+32.1%) |
| Dec 2003 | - | $241.60 K(-38.1%) | $1.46 M(-20.5%) |
| Sep 2003 | - | $390.00 K(-53.1%) | $1.84 M(+22.5%) |
| Jun 2003 | $1.50 M(-136.8%) | $831.70 K(<-9900.0%) | $1.50 M(-145.8%) |
| Mar 2003 | - | -$900.00(-100.1%) | -$3.28 M(-1.5%) |
| Dec 2002 | - | $618.80 K(+1092.3%) | -$3.33 M(-16.6%) |
| Sep 2002 | - | $51.90 K(-101.3%) | -$3.99 M(-2.2%) |
| Jun 2002 | -$4.08 M(+4297.8%) | -$3.95 M(+7641.8%) | -$4.08 M(+2536.4%) |
| Mar 2002 | - | -$51.00 K(+19.4%) | -$154.80 K(+23.7%) |
| Dec 2001 | - | -$42.70 K(+8.9%) | -$125.10 K(-3.6%) |
| Sep 2001 | - | -$39.20 K(+79.0%) | -$129.80 K(+39.9%) |
| Jun 2001 | -$92.80 K(+28.7%) | -$21.90 K(+2.8%) | -$92.80 K(+30.9%) |
| Mar 2001 | - | -$21.30 K(-55.1%) | -$70.90 K(+42.9%) |
| Dec 2000 | - | -$47.40 K(+2054.5%) | -$49.60 K(+2154.5%) |
| Sep 2000 | - | -$2200.00 | -$2200.00 |
| Jun 2000 | -$72.10 K(-4.5%) | - | - |
| Jun 1999 | -$75.50 K(<-9900.0%) | - | - |
| Jun 1998 | $0.00(0.0%) | - | - |
| Jun 1997 | $0.00 | - | - |
FAQ
- What is Eloxx Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual CFI year-on-year change?
- What is Eloxx Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly CFI year-on-year change?
- What is Eloxx Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals TTM CFI year-on-year change?
What is Eloxx Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of ELOX is -$66.00 K
What is the all time high annual CFI for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual cash flow from investing activities is $33.79 M
What is Eloxx Pharmaceuticals annual CFI year-on-year change?
Over the past year, ELOX annual cash flow from investing activities has changed by -$2.12 M (-103.21%)
What is Eloxx Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of ELOX is $233.00 K
What is the all time high quarterly CFI for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly cash flow from investing activities is $15.79 M
What is Eloxx Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, ELOX quarterly cash flow from investing activities has changed by +$281.00 K (+585.42%)
What is Eloxx Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of ELOX is $258.00 K
What is the all time high TTM CFI for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high TTM cash flow from investing activities is $42.87 M
What is Eloxx Pharmaceuticals TTM CFI year-on-year change?
Over the past year, ELOX TTM cash flow from investing activities has changed by +$344.00 K (+400.00%)